| Tye B Harrison, DO | |
|
600 W Hospital Rd, Brigham City, UT 84302-3006 | |
| (435) 734-2041 | |
| (435) 723-8028 |
| Full Name | Tye B Harrison |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 600 W Hospital Rd, Brigham City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053631069 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QS0010X | Family Medicine - Sports Medicine | 9857371-1204 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brigham City Community Hospital | Brigham city, UT | Hospital |
| Nell J Redfield Memorial Hospital | Malad, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brigham Medical Clinic, Inc. | 8628000809 | 6 |
News Archive
Researchers at the University of Granada and the Department of Nuclear Medicine, Hospital Virgen de las Nieves at Granada found that the metabolic imaging diagnosis technique based on the analysis of a structural analog of glucose labeled with a positron-emitting compound (18F) allows early diagnosis of gall bladder cancer, a relatively rare disease with high mortality rates among most patients suffering from it.
In the first study of its type in the malaria field, Seattle BioMed has been awarded an $8.9 million grant from the Bill & Melinda Gates Foundation to identify biomarkers that will allow malaria vaccine design based on robust predictors of protective immunity.
In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to degenerate. It is known today that the main culprits are viral proteins E6 and E7. Both proteins switch off different cellular control functions, thus promoting cell growth.
Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).
The American College of Occupational and Environmental Medicine and the American College of Preventive Medicine urged the adoption of stronger national policies to encourage preventive medicine - including in the workplace - during a special Congressional briefing Tuesday, July 9 in Washington, D.C.
› Verified 1 days ago
| Entity Name | Brigham Medical Clinic, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922119528 PECOS PAC ID: 8628000809 Enrollment ID: O20050908000720 |
News Archive
Researchers at the University of Granada and the Department of Nuclear Medicine, Hospital Virgen de las Nieves at Granada found that the metabolic imaging diagnosis technique based on the analysis of a structural analog of glucose labeled with a positron-emitting compound (18F) allows early diagnosis of gall bladder cancer, a relatively rare disease with high mortality rates among most patients suffering from it.
In the first study of its type in the malaria field, Seattle BioMed has been awarded an $8.9 million grant from the Bill & Melinda Gates Foundation to identify biomarkers that will allow malaria vaccine design based on robust predictors of protective immunity.
In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to degenerate. It is known today that the main culprits are viral proteins E6 and E7. Both proteins switch off different cellular control functions, thus promoting cell growth.
Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).
The American College of Occupational and Environmental Medicine and the American College of Preventive Medicine urged the adoption of stronger national policies to encourage preventive medicine - including in the workplace - during a special Congressional briefing Tuesday, July 9 in Washington, D.C.
› Verified 1 days ago
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
Researchers at the University of Granada and the Department of Nuclear Medicine, Hospital Virgen de las Nieves at Granada found that the metabolic imaging diagnosis technique based on the analysis of a structural analog of glucose labeled with a positron-emitting compound (18F) allows early diagnosis of gall bladder cancer, a relatively rare disease with high mortality rates among most patients suffering from it.
In the first study of its type in the malaria field, Seattle BioMed has been awarded an $8.9 million grant from the Bill & Melinda Gates Foundation to identify biomarkers that will allow malaria vaccine design based on robust predictors of protective immunity.
In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to degenerate. It is known today that the main culprits are viral proteins E6 and E7. Both proteins switch off different cellular control functions, thus promoting cell growth.
Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).
The American College of Occupational and Environmental Medicine and the American College of Preventive Medicine urged the adoption of stronger national policies to encourage preventive medicine - including in the workplace - during a special Congressional briefing Tuesday, July 9 in Washington, D.C.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tye B Harrison, DO 2561 S 1560 W Ste B, Woods Cross, UT 84087-2361 Ph: (801) 505-0821 | Tye B Harrison, DO 600 W Hospital Rd, Brigham City, UT 84302-3006 Ph: (435) 734-2041 |
News Archive
Researchers at the University of Granada and the Department of Nuclear Medicine, Hospital Virgen de las Nieves at Granada found that the metabolic imaging diagnosis technique based on the analysis of a structural analog of glucose labeled with a positron-emitting compound (18F) allows early diagnosis of gall bladder cancer, a relatively rare disease with high mortality rates among most patients suffering from it.
In the first study of its type in the malaria field, Seattle BioMed has been awarded an $8.9 million grant from the Bill & Melinda Gates Foundation to identify biomarkers that will allow malaria vaccine design based on robust predictors of protective immunity.
In the 1980s, Harald zur Hausen and his co-workers discovered that specific types of human papillomavirus (HPV) cause cervical cancer. Scientists soon found out how these pathogens cause cells to degenerate. It is known today that the main culprits are viral proteins E6 and E7. Both proteins switch off different cellular control functions, thus promoting cell growth.
Salix Pharmaceuticals, Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 7,718,608. This patent provides protection until August 2019 for rifaximin, which Salix markets in the United States under the trade names XIFAXAN® (200mg) and XIFAXAN550™ (550mg).
The American College of Occupational and Environmental Medicine and the American College of Preventive Medicine urged the adoption of stronger national policies to encourage preventive medicine - including in the workplace - during a special Congressional briefing Tuesday, July 9 in Washington, D.C.
› Verified 1 days ago
Dr. Jeffrey R Lish, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 984 Medical Dr Ste 1, Brigham City, UT 84302 Phone: 435-723-5248 Fax: 877-395-5866 | |
Dr. Thomas Michael Matthews, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 W Hospital Rd, Brigham City, UT 84302 Phone: 435-734-2041 Fax: 435-723-8028 | |
Scott Mitchell Nagao, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 984 Medical Dr Ste 1, Brigham City, UT 84302 Phone: 435-723-5248 | |
Dr. James Robert Taylor, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 600 W Hospital Rd, Brigham City, UT 84302 Phone: 435-734-2041 Fax: 435-723-8028 | |
Dr. Michael C Shaw, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 984 Medical Dr Ste 1, Brigham City, UT 84302 Phone: 435-723-5248 Fax: 435-723-5240 | |
Dr. Brian C Dawson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 984 Medical Dr Ste 1, Brigham City, UT 84302 Phone: 435-723-5248 Fax: 435-723-5240 |